Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure
Related Experiment Video
Updated: Jul 5, 2025

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation
Published on: March 17, 2023
Matteo Pagnesi1, Mauro Riccardi1, Mauro Chiarito2,3
1Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia.
Insights
Severe tricuspid regurgitation is linked to increased mortality in advanced heart failure patients. This study identified factors associated with severe tricuspid regurgitation, highlighting its prognostic significance.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Echocardiography
Background:
- Tricuspid regurgitation (TR) is common in heart failure (HF).
- The prognostic impact of TR in advanced HF requires further elucidation.
- Understanding TR's role is crucial for managing complex HF patients.
Purpose of the Study:
- To assess the role of tricuspid regurgitation in advanced heart failure.
- To identify clinical factors associated with severe TR.
- To evaluate the association between TR severity and mortality.
Main Methods:
- Observational, multicenter study (HELP-HF registry) of advanced HF patients.
- Stratification based on TR severity: none/mild, moderate, severe.
- Analysis of factors associated with severe TR and its impact on all-cause mortality.
Main Results:
- 1085 patients included; 18.8% had severe TR.
- Atrial fibrillation, prior valve surgery, furosemide dose, LVEF, mitral regurgitation, and pulmonary hypertension were linked to severe TR.
- 1-year mortality was 37.1% for severe TR vs. 21.4% for none/mild TR (P < 0.001).
- Severe TR independently predicted higher all-cause mortality (aHR 1.38, P=0.042).
Conclusions:
- Clinical and echocardiographic factors predict severe TR in advanced HF.
- Severe TR is an independent predictor of mortality in this population.
- Management strategies for advanced HF should consider TR severity.
Aims:
To evaluate the role of tricuspid regurgitation in advanced heart failure.
Methods:
The multicenter observational HELP-HF registry enrolled consecutive patients with heart failure and at least one 'I NEED HELP' criterion evaluated at four Italian centers between January 2020 and November 2021. Patients with no data on tricuspid regurgitation and/or receiving tricuspid valve intervention during follow-up were excluded. The population was stratified by no/mild tricuspid regurgitation vs. moderate tricuspid regurgitation vs. severe tricuspid regurgitation. Variables independently associated with tricuspid regurgitation, as well as the association between tricuspid regurgitation and clinical outcomes were investigated. The primary outcome was all-cause mortality.
Results:
Among the 1085 patients included in this study, 508 (46.8%) had no/mild tricuspid regurgitation, 373 (34.4%) had moderate tricuspid regurgitation and 204 (18.8%) had severe tricuspid regurgitation. History of atrial fibrillation, any prior valve surgery, high dose of furosemide, preserved left ventricular ejection fraction, moderate/severe mitral regurgitation and pulmonary hypertension were found to be independently associated with an increased likelihood of severe tricuspid regurgitation. Estimated rates of 1-year all-cause death were of 21.4, 24.5 and 37.1% in no/mild tricuspid regurgitation, moderate tricuspid regurgitation and severe tricuspid regurgitation, respectively (log-rank P < 0.001). As compared with nonsevere tricuspid regurgitation, severe tricuspid regurgitation was independently associated with a higher risk of all-cause mortality (adjusted hazard ratio 1.38, 95% confidence interval 1.01-1.88, P = 0.042), whereas moderate tricuspid regurgitation did not.
Conclusion:
In a contemporary, real-world cohort of patients with advanced heart failure, several clinical and echocardiographic characteristics are associated with an increased likelihood of severe tricuspid regurgitation. Patients with severe tricuspid regurgitation have an increased risk of mortality.
Related Concept Videos
Pathophysiology of Heart Failure
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

